Loading...
Indian Pharmaceutical Exporter · #4 for Imipenem · $750.0K export value · DGFT Verified
Sun Pharmaceutical Industries Ltd is the #4 Indian exporter of Imipenem with $750.0K in export value and 15 verified shipments. Sun Pharmaceutical Industries Ltd holds a 2.2% market share in Imipenem exports across 8 countries.
| VIETNAM |
| $288.4K |
| 6 |
| 5.2% |
| THAILAND | $281.9K | 7 | 5.0% |
| VIETNAM DEMOCRATIC REP OF | $250.0K | 5 | 4.5% |
| SOUTH AFRICA | $200.0K | 4 | 3.6% |
| PHILIPPINES | $150.0K | 3 | 2.7% |
| CANADA | $120.4K | 3 | 2.2% |
Sun Pharmaceutical Industries Ltd exports Imipenem to 19 countries. The largest destination is BELGIUM accounting for 30.4% of Sun Pharmaceutical Industries Ltd's Imipenem shipments, followed by MOROCCO (19.6%) and MYANMAR (9.1%). These destinations reflect Sun Pharmaceutical Industries Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $1.3M | 31 |
| M/S. SUN PHARMACEUTICALS MOROCCO LL | MOROCCO | $529.4K | 12 |
| YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN | BELGIUM | $350.0K | 7 |
| M/S. HAPHARCO J.S.C BRANCH | VIETNAM | $288.4K | 6 |
| M S HAPHARCO J S C BRANCH | VIETNAM DEMOCRATIC REP OF | $250.0K | 5 |
| MS SUN PHARMACEUTICALS MOROCCO LL | MOROCCO | $222.9K | 5 |
| IDA FOUNDATION THE NETHERLANDS | NETHERLANDS | $200.0K | 4 |
| M S RANBAXY PHARMACEUTICALS PTY LTD | SOUTH AFRICA | $200.0K | 4 |
| M/S. JDS CO., LTD. | MYANMAR | $144.0K | 3 |
| MSSUN PHARMACEUTICALS MOROCCO LLC | MOROCCO | $143.3K | 3 |
Sun Pharmaceutical Industries Ltd supplies Imipenem to 49 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by M/S. SUN PHARMACEUTICALS MOROCCO LL (MOROCCO) and YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN (BELGIUM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $20.1M worth of Imipenem through 803 shipments from 140 suppliers to 94 countries, serving 302 buyers globally. Sun Pharmaceutical Industries Ltd contributes $750.0K to this total, accounting for 2.2% of India's Imipenem exports. Sun Pharmaceutical Industries Ltd ships Imipenem to 19 countries through 49 buyers.
Sun Pharmaceutical Industries Ltd's average Imipenem shipment value is $50.0K per consignment, based on 15 shipments totaling $750.0K. The largest destination is BELGIUM (30.4% of Sun Pharmaceutical Industries Ltd's Imipenem exports).
Sun Pharmaceutical Industries Ltd ranks #4 among 140 Indian Imipenem exporters with a 2.2% market share. The top 3 exporters are VENUS REMEDIES LIMITED ($9.7M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($6.0M), PROTECH BIO SYSTEMS PRIVATE LIMITED ($950.0K). Sun Pharmaceutical Industries Ltd processed 15 shipments to 8 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| IMIPENEM/CILASTATIN POWDER FOR SOLUTION | $256.9K | 6 |
| IMIPENEM+CIL BASICS-S INJ 500MG PACK: 10 | $150.0K | 3 |
| IMIPENEM & CILASTATIN FOR INJECTION 500MG ( IMIPENEM+CIL RXY INJ 500MG ) PACK :1 VIAL BATCH : DFF2081A EACH VIAL CONTS: | $145.5K | 3 |
| IMIPENEM/CILASTATIN POWDER FOR SOLUTIONFOR INFUSION 500MG/500MG (EACH VIAL CONT. IMIPENEM 500MG, CILASTATIN 500MG) [PAC | $140.9K | 3 |
| IMIPENEM CILASTATINE INJ 500MG/500MG (IM | $100.0K | 2 |
| IMIPENEM CILASTATIN POWDER FOR SOLUTION | $100.0K | 2 |
| IMIPENEM CILASTATIN POWDER FOR SOLUTIONFOR INFUSION 500 500MG EACH VIAL CONTAINS IMIPENEM 500MG CILASTATIN 500MG PACK | $100.0K | 2 |
| CILAPEN INJ 500MG 100ML PACK:100ML BOTTBATCH:DFE5211A EACH VIAL CONTS. IMIPENEMEQ TO 500MG & CILASTATIN 500MG | $100.0K | 2 |
| BACQURE INJ.500MG EACH VIAL CONT IMIPENEM PH EUR/USPSTERILEEQ.TO ANHYDROUS IMIPENEM 500MG CILASTATIN SODIUM PH.EUR/USP | $100.0K | 2 |
| BACQURE INJECTION 500MG PACK : 1 Vial Batch : DFG1535D EACH VIAL CONTAINS IMIPENEM PH, EUR/USP (STERILE) EQUIVALENT TO | $100.0K | 2 |
Sun Pharmaceutical Industries Ltd exports 109 distinct Imipenem formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IMIPENEM/CILASTATIN POWDER FOR SOLUTION with 6 shipments worth $256.9K.
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $6.0M | 119 | 17 | $50.0K |
| 5 | PROTECH BIO SYSTEMS PRIVATE LIMITED | $950.0K | 19 | 2 | $50.0K |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LTD ★ | $750.0K | 15 | 8 | $50.0K |
| 3 | SWISS PARENTERALS LIMITED | $450.0K | 9 | 6 | $50.0K |
| 6 | M J BIOPHARM PRIVATE LIMITED | $450.0K | 9 | 2 | $50.0K |
Sun Pharmaceutical Industries Ltd ranks #4 among 140 Indian Imipenem exporters. Average shipment value of $50.0K compared to the market average of $143.4K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and PROTECH BIO SYSTEMS PRIVATE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 114 | 14.2% |
| DELHI AIR | 83 | 10.3% |
| SAHAR AIR | 76 | 9.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 57 | 7.1% |
| NHAVA SHEVA SEA (INNSA1) | 37 | 4.6% |
| Delhi Air | 34 | 4.2% |
| DHANNAD ICD | 30 | 3.7% |
| DHANNAD ICD (INDHA6) | 27 | 3.4% |
Latest developments and market context
Detailed market intelligence for Imipenem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 302+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sun Pharmaceutical Industries Ltd's Imipenem exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sun Pharmaceutical Industries Ltd
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Sun Pharmaceutical Industries Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Imipenem. For current shipment-level data, contact TransData Nexus.